Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Kindred: Family Centered Approaches to Promoting Cascade Screening for Hereditary Cancer Syndromes Among African Americans

NCT07542405 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.

NCT NCT07542405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07542405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Kindred: Family Centered Approaches to Promoting Cascade Screening for Hereditary Cancer Syndromes Among African Americans
Lead sponsor
University of Michigan Rogel Cancer Center
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 15, 2026
Completion date
June 30, 2028
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca1-related hereditary breast and ovarian cancer syndrome, brca2-related hereditary breast and ovarian cancer syndrome, hereditary neoplastic syndrome, lynch syndrome